Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
Robert T. Jensen, Lisa Bodei, Jaume Capdevila, et al.
Neuroendocrinology (2018) Vol. 108, Iss. 1, pp. 26-36
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
Jonathan Strosberg, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, et al.
Pancreas (2017) Vol. 46, Iss. 6, pp. 707-714
Open Access | Times Cited: 322
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Þorvarður R. Hálfdánarson, Jonathan Strosberg, Laura Tang, et al.
Pancreas (2020) Vol. 49, Iss. 7, pp. 863-881
Closed Access | Times Cited: 142
Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors
Kira Oleinikov, Alain Dancour, Julia Epshtein, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 7, pp. 2637-2647
Open Access | Times Cited: 111
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
James C. Yao, Emily K. Bergsland, Rahul Aggarwal, et al.
The Oncologist (2022) Vol. 27, Iss. 11, pp. 940-951
Open Access | Times Cited: 47
PANCREATIC NEUROENDOCRINE NEOPLASMS (pNENs): GENETIC AND ENVIRONMENTAL BIOMARKERS FOR RISK OF OCCURRENCE AND PROGNOSIS
Matteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, et al.
Seminars in Cancer Biology (2025)
Closed Access | Times Cited: 1
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
Lingaku Lee, Tetsuhide Ito, Robert T. Jensen
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 12, pp. 1029-1050
Open Access | Times Cited: 68
Management of Functional Pancreatic Neuroendocrine Neoplasms
Ludovica Magi, Matteo Marasco, Maria Rinzivillo, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 725-741
Open Access | Times Cited: 22
Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study
Stefano Partelli, Luca Landoni, Mirco Bartolomei, et al.
British journal of surgery (2024) Vol. 111, Iss. 9
Open Access | Times Cited: 5
Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
Gitta Boons, Timon Vandamme, Laura Mariën, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 2, pp. 338-349
Open Access | Times Cited: 28
Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review
Anna Pellat, Romain Coriat
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1677-1677
Open Access | Times Cited: 29
Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors
Ashley L. Titan, Jeffrey A. Norton, Andrea T. Fisher, et al.
JAMA Network Open (2020) Vol. 3, Iss. 11, pp. e2024318-e2024318
Open Access | Times Cited: 29
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours
Alina S. Ritter, Jelte Poppinga, Kira C. Steinkraus, et al.
Current Oncology Reports (2025)
Open Access
Preclinical Models of Neuroendocrine Neoplasia
Andrew J. H. Sedlack, Kimia Saleh-Anaraki, Suresh Kumar, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5646-5646
Open Access | Times Cited: 16
Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets
Takayuki Oguma, Takanori Kanazawa, Yukiko Kaneko, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 917-928
Closed Access | Times Cited: 3
Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges
Jie Yan, Shuangni Yu, Congwei Jia, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 1, pp. 188367-188367
Open Access | Times Cited: 22
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
Anna Pellat, Anne‐Ségolène Cottereau, Lola‐Jade Palmieri, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2448-2448
Open Access | Times Cited: 16
A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations
Przemysław Soczomski, Beata Jurecka‐Lubieniecka, Aleksandra Krzywon, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 16
The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
Lukas Geisler, Raphael Mohr, Joeri Lambrecht, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8569-8569
Open Access | Times Cited: 15
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers
Thaer S. A. Abdalla, Monika Klinkhammer‐Schalke, Sylke Ruth Zeißig, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8535-8543
Open Access | Times Cited: 6
The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities
Kate Young, Naureen Starling, Anguraj Sadanandam
Seminars in Cancer Biology (2019) Vol. 61, pp. 132-138
Closed Access | Times Cited: 16
Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters
Dirk‐Jan van Beek, Sjoerd Nell, Helena M. Verkooijen, et al.
Surgery (2020) Vol. 169, Iss. 4, pp. 963-973
Open Access | Times Cited: 15
Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
Dirk‐Jan van Beek, Sjoerd Nell, Wessel M.C.M. Vorselaars, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 8, pp. 4387-4399
Open Access | Times Cited: 14
Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors
Yu Chen, Tatsuki Yamamoto, Yura Takahashi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 5
Neuroendocrine neoplasia goes molecular — time for a change
Guido Rindi, Bertram Wiedenmann
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 149-150
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top